Considering that CMA regulatory mechanisms in some cancer cells act differently than in healthy cells [94] (Figure 1), several CMA control points reported must be validated in each type of cancer: (1) the first one is constituted by three proteins: mTOR2, Akt, and PHLPP1. This evidence concerns the gene PHLPP1 and cancer.